{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:25:13Z","timestamp":1787027113187,"version":"build-2736575974"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Multiple studies indicate that iron chelators enhance their anti-cancer properties by inducing NDRG1, a known tumor and metastasis suppressor. However, the exact role of NDRG1 remains controversial, as newer studies have shown that NDRG1 can also act as an oncogene. Our group recently introduced mitochondrially targeted iron chelators deferoxamine (mitoDFO) and deferasirox (mitoDFX) as effective anti-cancer agents. In this study, we evaluated the ability of these modified chelators to induce NDRG1 and the role of NDRG1 in breast cancer. We demonstrated that both compounds specifically increase NDRG1 without inducing other NDRG family members. We have documented that the effect of mitochondrially targeted chelators is at least partially mediated by GSK3\u03b1\/\u03b2, leading to phosphorylation of NDRG1 at Thr\n                    <jats:sup>346<\/jats:sup>\n                    and to a lesser extent on Ser\n                    <jats:sup>330<\/jats:sup>\n                    . Loss of\n                    <jats:italic>NDRG1<\/jats:italic>\n                    increases cell death induced by mitoDFX. Notably, MDA-MB-231 cells lacking NDRG1 exhibit reduced extracellular acidification rate and grow slower than parental cells, while the opposite is true for ER+ MCF7 cells. Moreover, overexpression of full-length NDRG1 and the N-terminally truncated isoform (59112) significantly reduced sensitivity towards mitoDFX in ER+ cells. Furthermore, cells overexpressing full-length NDRG1 exhibited a significantly accelerated tumor formation, while its N-terminally truncated isoforms showed significantly impaired capacity to form tumors. Thus, overexpression of full-length NDRG1 promotes tumor growth in highly aggressive triple-negative breast cancer.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2024.1422369","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:50:09Z","timestamp":1719276609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation"],"prefix":"10.3389","volume":"15","author":[{"given":"Sukanya B.","family":"Jadhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Vondrackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Potomova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Sandoval-Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Smigova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Klanicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rosel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Brabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stursa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Truksa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1038\/sj.onc.1207734","article-title":"Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression","volume":"23","author":"Bandyopadhyay","year":"2004","journal-title":"Oncogene"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","article-title":"Iron addiction: a novel therapeutic target in ovarian cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1158\/1535-7163.MCT-15-1021","article-title":"Mitochondrial targeting of metformin enhances its activity against pancreatic cancer","volume":"15","author":"Boukalova","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/cells10092382","article-title":"The oncogenic signaling disruptor, NDRG1: molecular and cellular mechanisms of activity","volume":"10","author":"Chekmarev","year":"2021","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1074\/jbc.M112.350470","article-title":"The iron chelators Dp44mT and DFO inhibit TGF-\u03b2-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1)","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"W242-W245","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jnci\/djac031","article-title":"RE: NDRG1 in aggressive breast cancer progression and brain metastasis","volume":"114","author":"de Nonneville","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"B8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/omi.2011.0146","article-title":"NDRG4 is downregulated in glioblastoma and inhibits cell proliferation","volume":"16","author":"Ding","year":"2012","journal-title":"OMICS"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgm200","article-title":"NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states","volume":"29","author":"Ellen","year":"2008","journal-title":"Carcinogenesis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbcan.2013.11.002","article-title":"Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy","volume":"1845","author":"Fang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1158\/1078-0432.CCR-05-1962","article-title":"17Beta-estradiol induces down-regulation of Cap43\/NDRG1\/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells","volume":"12","author":"Fotovati","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/cells9020407","article-title":"Complex mitochondrial dysfunction induced by TPP(+)-Gentisic acid and mitochondrial translation inhibition by doxycycline evokes synergistic lethality in breast cancer cells","volume":"9","author":"Fuentes-Retamal","year":"2020","journal-title":"Cells"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e21347","DOI":"10.1096\/fj.202002279R","article-title":"Breaking the cycle: targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma","volume":"35","author":"Geleta","year":"2021","journal-title":"FASEB J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e00042","DOI":"10.1042\/BSR20130042","article-title":"Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells","volume":"33","author":"Ghalayini","year":"2013","journal-title":"Biosci. Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B16","doi-asserted-by":"publisher","first-page":"144552","DOI":"10.1016\/j.gene.2020.144552","article-title":"Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC","volume":"741","author":"Guo","year":"2020","journal-title":"Gene"},{"key":"B17","doi-asserted-by":"publisher","first-page":"33568","DOI":"10.1074\/jbc.M114.599480","article-title":"The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: persistent induction of autophagosome synthesis and impairment of lysosomal integrity","volume":"289","author":"Gutierrez","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18632\/oncotarget.6228","article-title":"Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1158\/0008-5472.CAN-19-0438","article-title":"Bidirectional regulation between NDRG1 and GSK3\u03b2 controls tumor growth and is targeted by differentiation inducing factor-1 in glioblastoma","volume":"80","author":"Ito","year":"2020","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"575692","DOI":"10.1101\/2024.01.17.575692","article-title":"Mitochondrially targeted deferasirox kills cancer cells via simultaneous iron deprivation and ferroptosis induction","volume":"2024","author":"Jadhav","year":"2024","journal-title":"bioRxiv."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41523-019-0106-x","article-title":"NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients","volume":"5","author":"Jandrey","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180907","article-title":"NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma","volume":"38","author":"Jing","year":"2018","journal-title":"Biosci. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00418-018-1650-4","article-title":"Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes","volume":"149","author":"Jobe","year":"2018","journal-title":"Histochem Cell. Biol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/2056-4538.12364","article-title":"NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis","volume":"10","author":"Joshi","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms20020273","article-title":"Iron as a central player and promising target in cancer progression","volume":"20","author":"Jung","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1749-6632.1965.tb54077.x","article-title":"The biochemistry of desferrioxamine and its relation to iron metabolism","volume":"119","author":"Keberle","year":"1964","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B28","first-page":"3886","article-title":"NDRG3 protein expression is associated with aggressive biologic phenotype and unfavorable outcome in patients with invasive breast cancer","volume":"12","author":"Kim","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2014.06.023","article-title":"N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3\/Snail signaling","volume":"354","author":"Kim","year":"2014","journal-title":"Cancer Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0159073","DOI":"10.1371\/journal.pone.0159073","article-title":"Abundant NDRG2 expression is associated with aggressiveness and unfavorable patients' outcome in basal-like breast cancer","volume":"11","author":"Kloten","year":"2016","journal-title":"PLoS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1093\/carcin\/bgl146","article-title":"The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer","volume":"27","author":"Kovacevic","year":"2006","journal-title":"Carcinogenesis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/carcin\/bgr046","article-title":"The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms","volume":"32","author":"Kovacevic","year":"2011","journal-title":"Carcinogenesis"},{"key":"B33","first-page":"4439","article-title":"Inhibition of tumor cell growth by RTP\/rit42 and its responsiveness to p53 and DNA damage","volume":"58","author":"Kurdistani","year":"1998","journal-title":"Cancer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbcan.2014.01.005","article-title":"Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial-mesenchymal transition","volume":"1845","author":"Lane","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1182\/blood-2004-05-1866","article-title":"Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation","volume":"104","author":"Le","year":"2004","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.3390\/cancers13236112","article-title":"NDRG2 expression in breast cancer cells downregulates PD-L1 expression and restores T cell proliferation in tumor-coculture","volume":"13","author":"Lee","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/ijms17091435","article-title":"The iron chelator, Dp44mT, effectively inhibits human oral squamous cell carcinoma cell growth in vitro and in vivo","volume":"17","author":"Lee","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1073\/pnas.1120043109","article-title":"Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbrc.2007.04.089","article-title":"Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines","volume":"358","author":"Liu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","article-title":"Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer","volume":"401","author":"Liu","year":"","journal-title":"Cancer Lett."},{"key":"B41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/emmm.201100190","article-title":"N-myc downstream regulated gene 1 modulates Wnt-\u03b2-catenin signalling and pleiotropically suppresses metastasis","volume":"4","author":"Liu","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3892\/ijo.2017.3938","article-title":"A new facet of NDRG1 in pancreatic ductal adenocarcinoma: suppression of glycolytic metabolism","volume":"50","author":"Liu","year":"","journal-title":"Int. J. Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1124\/mol.112.081893","article-title":"The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action","volume":"83","author":"Lui","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.1074\/jbc.R117.776393","article-title":"Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling","volume":"292","author":"Menezes","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1089\/ars.2012.4540","article-title":"Novel chelators for cancer treatment: where are we now?","volume":"18","author":"Merlot","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"B46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbrc.2010.04.100","article-title":"Identification of sites subjected to serine\/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)\/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells","volume":"396","author":"Murakami","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-020-1998-1","article-title":"Mechanical regulation of glycolysis via cytoskeleton architecture","volume":"578","author":"Park","year":"","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1074\/jbc.RA119.011341","article-title":"Thiosemicarbazones suppress expression of the c-Met oncogene by mechanisms involving lysosomal degradation and intracellular shedding","volume":"295","author":"Park","year":"","journal-title":"J. Biol. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1016\/j.bbadis.2018.04.011","article-title":"Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1","volume":"1864","author":"Park","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2019.05.020","article-title":"Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer","volume":"157","author":"Park","year":"","journal-title":"Free Radic. Biol. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and Iron: current questions","volume":"10","author":"Paul","year":"2017","journal-title":"Expert Rev. Hematol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1039\/c7mt00116a","article-title":"The elemental role of iron in DNA synthesis and repair","volume":"9","author":"Puig","year":"2017","journal-title":"Metallomics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14670\/HH-29.10.535","article-title":"Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy","volume":"29","author":"Ren","year":"2014","journal-title":"Histol. Histopathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOH.0000000000000494","article-title":"New insights into the links between hypoxia and iron homeostasis","volume":"26","author":"Renassia","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1089\/ars.2016.6677","article-title":"Selective disruption of respiratory supercomplexes as a new strategy to suppress Her2high breast cancer","volume":"26","author":"Rohlenova","year":"2017","journal-title":"Antioxid. Redox Signal"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.bbadis.2019.02.008","article-title":"Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1","volume":"1865","author":"Sahni","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.taap.2016.08.018","article-title":"Destabilization of mitochondrial functions as a target against breast cancer progression: role of TPP(+)-linked-polyhydroxybenzoates","volume":"309","author":"Sandoval-Acuna","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1158\/0008-5472.CAN-20-1628","article-title":"Targeting mitochondrial iron metabolism suppresses tumor growth and metastasis by inducing mitochondrial dysfunction and mitophagy","volume":"81","author":"Sandoval-Acuna","year":"2021","journal-title":"Cancer Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"608722","DOI":"10.3389\/fonc.2020.608722","article-title":"SGK1 in human cancer: emerging roles and mechanisms","volume":"10","author":"Sang","year":"2020","journal-title":"Front. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-018-0980-4","article-title":"NDRG1 regulates neutral lipid metabolism in breast cancer cells","volume":"20","author":"Sevinsky","year":"2018","journal-title":"Breast Cancer Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbagen.2011.08.002","article-title":"The long history of iron in the Universe and in health and disease","volume":"1820","author":"Sheftel","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"B63","doi-asserted-by":"publisher","first-page":"106806","DOI":"10.1016\/j.phrs.2023.106806","article-title":"Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-progesterone-androgen- and prolactin-receptors in breast cancer","volume":"193","author":"Shehadeh-Tout","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41388-017-0118-7","article-title":"NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21\/p27 axis","volume":"37","author":"Shen","year":"2018","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e75473","DOI":"10.1371\/journal.pone.0075473","article-title":"The expression and localization of N-myc downstream-regulated gene 1 in human trophoblasts","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1056\/NEJM198810203191603","article-title":"Body iron stores and the risk of cancer","volume":"319","author":"Stevens","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/ars.2013.5594","article-title":"Mitochondrially targeted vitamin E succinate modulates expression of mitochondrial DNA transcripts and mitochondrial biogenesis","volume":"22","author":"Truksa","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.3390\/cancers12123711","article-title":"NDRG1 expression is an independent prognostic factor in inflammatory breast cancer","volume":"12","author":"Villodre","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jnci\/djab222","article-title":"NDRG1 in aggressive breast cancer progression and brain metastasis","volume":"114","author":"Villodre","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"B71","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.18632\/oncotarget.2328","article-title":"The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)\/gp130\/STAT3 pathway","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1756284819858507","DOI":"10.1177\/1756284819858507","article-title":"Characterization of the prognostic values of the NDRG family in gastric cancer","volume":"12","author":"Yu","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.4161\/cc.6.16.4603","article-title":"Tuning cell cycle regulation with an iron key","volume":"6","author":"Yu","year":"2007","journal-title":"Cell. Cycle"},{"key":"B74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/21655979.2021.2006974","article-title":"MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN\/AKT pathway","volume":"13","author":"Zhai","year":"2022","journal-title":"Bioengineered"},{"key":"B75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13402-020-00502-y","article-title":"Dp44mT, an iron chelator, suppresses growth and induces apoptosis via RORA-mediated NDRG2-IL6\/JAK2\/STAT3 signaling in glioma","volume":"43","author":"Zhou","year":"2020","journal-title":"Cell. Oncol. (Dordr)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.3390\/ijms19051545","article-title":"Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer","volume":"19","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1422369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:50:16Z","timestamp":1719276616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1422369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":75,"alternative-id":["10.3389\/fphar.2024.1422369"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1422369","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"article-number":"1422369"}}